Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by JaymeKnyx1on Feb 08, 2018 10:08am
120 Views
Post# 27525956

U.S. Senate Agrees to lift ban and a 2yr prosecution freeze

U.S. Senate Agrees to lift ban and a 2yr prosecution freezeAccording to the Associated Press, Senate leaders announced Wednesday they have reached an agreement on a two-year budget deal. The agreement comes just a day after the House of Representatives approved a much shorter-term budget deal, which extends government funding to March 23rd. Both the House approved bill, and the 2-year agreement reached by the Senate, includes and extension of the Rohrabacher-Farr Amendment, which prohibits the Department of Justice from using funds to enforce federal cannabis laws in states that have legalized the plant for medical use. The extension comes despite strong opposition from Attorney General Jeff Sessions. Both the House-approved extension, and the Senate agreement, also include extensions of an amendment that protects state laws allowing for the cultivation and research of hemp. President Trump says he supports the Senates 2-year deal. Although these amendments dont protect state laws allowing recreational marijuana, it does clarify that the Department of Justice which includes the Drug Enforcement Administration can not attack users, growers or distributors of medical marijuana in states where its legal. These protections have been in place since 2014. https://thejointblog.com/u-s-senate-agrees-2-year-budget-deal-includes-protections-medical-marijuana-hemp/
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse